Concord Biotech

Starting with a single product in 2000, Concord Biotech is now a leading global provider of fermentation-based active pharmaceutical ingredients (APIs). The company's vision is to create products using biotechnology that enrich people's lives, constantly improving its expertise in the field. Its mission is to become a global leader in biotechnology-based products through dedicated research and development for long-term business success. It specializes in a strong portfolio of APIs for critical treatments in areas like immunosuppressants, oncology, anti-infectives, and antifungals. To maintain quality and efficiency, the company is backward-integrated, meaning it manufactures its own key starting materials for production. Globally, Concord serves over 250 customers across more than 70 countries with its wide range of APIs and formulations.;